英文名稱 | Anti-Human F9xF10 Bispecific Antibody(Emicizumab;RO 5534262, ACE 910;RG6013,hBS910;coagulation factor 10, coagulation factor X;coagulation factor 9, coagulation factor IX) |
---|---|
中文名稱 | 依米賽珠單抗;艾美賽珠單抗 |
CAS號(hào) | 1610943-06-0 |
儲(chǔ)存條件 | store at -20°C |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無牌價(jià)信息,您可以發(fā)送詢價(jià),我們會(huì)盡快給你回復(fù)。 |
英文名稱 | Anti-Human F9xF10 Bispecific Antibody(Emicizumab;RO 5534262, ACE 910;RG6013,hBS910;coagulation factor 10, coagulation factor X;coagulation factor 9, coagulation factor IX) |
---|---|
中文名稱 | 依米賽珠單抗;艾美賽珠單抗 |
CAS號(hào) | 1610943-06-0 |
儲(chǔ)存條件 | store at -20°C |
Emicizumab is a bispecific monoclonal antibody that simulates the function of coagulation Factor VIII by bridging activated Factor IX and Factor X. It's approved for routine prophylaxis to prevent or reduce bleeding episodes in adults and children with hemophilia A, with or without Factor VIII inhibitors.
A hemophilia A mouse model for the in vivo assessment of emicizumab function.
PMID: 32369559 DOI: 10.1182/blood.2019004334